Sign in

or Register now

MyDiabetesCentral.com

See all of our health sites at www.HealthCentral.com
Wednesday, November, 25, 2009
  • Font size
Shedding Light on the Co-morbidities of DiabetesThe Complications of Having Rheumatoid Arthritis and Diabetes

SGLT2 inhibitors -- an upcoming class of medications for diabetes

Dr. Bill Quick
Dr. Bill Quick
Close
Physician and Medical Director of DiabetesMonitor.com

Dr. Bill Quick and his wife Steph are the authors of one of the ...

Dr. Bill Quick

Sunday, March 15, 2009
View All of Dr. Bill Quick's Posts
Sodium-glucose transporter-2 (SGLT2) is the name of a "transporter protein" in the kidneys that has become a hot topic in diabetes research. In people with normal blood glucose (BG) levels, glucose is not excreted into the urine, but thanks to SGLT2, remains in the body. Which is a good thing: gluc...
  1. don't pee out the Mg
    frankenduf
    Wednesday, March 18, 2009 at 05:21 PM

    interesting post- i found the Mg results the most intriguing- magnesium deficiency has been implicated in the etiology of insulin resistance- and the suspected process is via urinary losses- studies have shown that higher Mg intake can increase insulin sensitivity, but from this post idea, decreasing urinary losses of Mg might also work to increase insulin sensitivity- and i've also wondered if there's any link between chronic diuretic use and insulin resistance, via the same process of increased Mguria

    Reply
  2. Can long term use damage kidney?
    A.U.Arvindekar
    Thursday, March 26, 2009 at 06:24 AM

    Loss of glucose from the urine could lead to a continued high concentration of glucose in the kidneys. would it lead to excessive glycation of kidney proteins and thereby damage of kidneys

    Reply
    re: Can long term use damage kidney?
    Dr. Bill Quick
    Thursday, March 26, 2009 at 07:16 AM

    You identify one of zillions of conceivable issues with this new class of drugs; at this moment I have no idea, but it would seem likely that your question won't be answered until big studies are done that last a longer time, or perhaps until the drug has been on the market for several years.

     

    Which, of course, is why the FDA and other regulatory authorities in other countries require large trials (called Phase III trials) that last at least a year before they will consider approving a drug for general use. And why they require continuing surveillance after they're approved.

     

    Good question!

    Reply
  • Font size
  • Bookmark
  • Thank you for your input
  • Save
  • RSS
  • Report Abuse

Ask a Question

Get answers from our experts and community members.

View all questions (2366) >